These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 27282619

  • 1. Osteopontin regulates proliferation, apoptosis, and migration of murine claudin-low mammary tumor cells.
    Saleh S, Thompson DE, McConkey J, Murray P, Moorehead RA.
    BMC Cancer; 2016 Jun 10; 16():359. PubMed ID: 27282619
    [Abstract] [Full Text] [Related]

  • 2. Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.
    Franks SE, Campbell CI, Barnett EF, Siwicky MD, Livingstone J, Cory S, Moorehead RA.
    Oncogene; 2012 Jul 05; 31(27):3298-309. PubMed ID: 22020329
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
    Prat A, Karginova O, Parker JS, Fan C, He X, Bixby L, Harrell JC, Roman E, Adamo B, Troester M, Perou CM.
    Breast Cancer Res Treat; 2013 Nov 05; 142(2):237-55. PubMed ID: 24162158
    [Abstract] [Full Text] [Related]

  • 6. Murine mammary tumor cells with a claudin-low genotype.
    Campbell CI, Thompson DE, Siwicky MD, Moorehead RA.
    Cancer Cell Int; 2011 Aug 16; 11():28. PubMed ID: 21846397
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S, Liu JC, Kim D, Datti A, Zacksenhaus E.
    Breast Cancer Res; 2016 Jan 19; 18(1):9. PubMed ID: 26781438
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated PIK3CG induction.
    Zhang S, Chung WC, Wu G, Egan SE, Miele L, Xu K.
    Cancer Res; 2015 May 15; 75(10):1936-43. PubMed ID: 25808869
    [Abstract] [Full Text] [Related]

  • 17. [The Expression and Biological Function of claudin-23 in Colorectal Cancer].
    Chen W, Zhu XN, Wang J, Wang YP, Yang JL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May 15; 49(3):331-336. PubMed ID: 30014629
    [Abstract] [Full Text] [Related]

  • 18. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
    Ortiz-Martínez F, Perez-Balaguer A, Ciprián D, Andrés L, Ponce J, Adrover E, Sánchez-Payá J, Aranda FI, Lerma E, Peiró G.
    Hum Pathol; 2014 Mar 15; 45(3):504-12. PubMed ID: 24440093
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin accelerates the development and metastasis of bladder cancer via activating JAK1/STAT1 pathway.
    Zhang N, Li F, Gao J, Zhang S, Wang Q.
    Genes Genomics; 2020 Apr 15; 42(4):467-475. PubMed ID: 32088853
    [Abstract] [Full Text] [Related]

  • 20. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE, Monard D.
    Cancer Res; 2009 Jul 15; 69(14):5690-8. PubMed ID: 19584287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.